Dynavax

Dynavax shares dip after FDA asks for more time to sort out Heplisav post-marketing plan
Dynavax shares dip after FDA asks for more time to sort out Heplisav post-marketing plan
Endpoints
Dynavax
FDA
Heplisav
vaccines
hepatitis B
Flag link:
Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel
Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel
Yahoo/Reuters
Dynavax
vaccines
hepatitis B
Heplisav
FDA
advisory panels
Flag link:
Dynavax shares slide as FDA review spotlights a hazy safety issue for Heplisav
Dynavax shares slide as FDA review spotlights a hazy safety issue for Heplisav
Endpoints
Dynavax
FDA
Heplisav
hepatitis B
vaccines
Flag link:
5 Biotech Stocks With Major Catalysts in July
5 Biotech Stocks With Major Catalysts in July
Motley Fool
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Flag link:
Dynavax's stock plunges after disappointing FDA response to Hep-B treatment
Dynavax's stock plunges after disappointing FDA response to Hep-B treatment
Marketwatch
Dynavax
hepatitis B
FDA
HEPLISAV-B
Flag link:
What Will Dynavax Do if Heplisav-B Is Rejected?
What Will Dynavax Do if Heplisav-B Is Rejected?
Motley Fool
Dynavax
HEPLISAV-B
vaccines
hepatitis B
FDA
Flag link:
FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk
FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk
TheStreet.com
Dynavax
vaccines
hepatitis B
FDA
Heplisav
Flag link:
5 Small-Cap Biotechs With Big Potential
5 Small-Cap Biotechs With Big Potential
TheStreet.com
biotech
Portola Pharmaceuticals
Progenics
Redhill Biopharma
Dynavax
Amicus Therapeutics
Flag link:
Dynavax, GlaxoSmithKline Battling In Same Industry: Who Will Win?
Dynavax, GlaxoSmithKline Battling In Same Industry: Who Will Win?
Yahoo/Benzinga
Dynavax
GSK
HBV-23
vaccines
hepatitis B
Engerix-B
Flag link:
3 Scorned Biotechs Destined to Rebound
3 Scorned Biotechs Destined to Rebound
TheStreet.com
Merrimack Pharmaceuticals
Relypsa
Amgen
AbbVie
Dynavax
Flag link:
2 Attractive Small Biotech Stocks That Could Become Buyout Targets
2 Attractive Small Biotech Stocks That Could Become Buyout Targets
Seeking Alpha
M&A
biotech
Conatus Pharmaceuticals
Dynavax
Amgen
Celgene
Gilead Sciences
Flag link:
Dynavax & AstraZeneca Alter Agreement for Asthma Product
Dynavax & AstraZeneca Alter Agreement for Asthma Product
Yahoo/Zacks.com
asthma
AstraZeneca
Dynavax
AZD1419
Flag link:
Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma
Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma
Yahoo
Dynavax
TLR-9
immuno-oncology
B-cell lymphoma
SD-101
Flag link:
Radiant/CRA Enroll 8,000 for Hepatitis B Vaccine Study
Radiant/CRA Enroll 8,000 for Hepatitis B Vaccine Study
AZ Big Media
Radiant CRA
Dynavax
vaccines
hepatitis B
Flag link:
After Idenix: The Next Four Biotech Buyout Candidates
After Idenix: The Next Four Biotech Buyout Candidates
24/7 Wall St
Idenix
M&A
Merck
Biocryst
Dynavax
InterMune
Vertex Pharmaceuticals
Flag link:
Five Small Biotech Stocks Analysts Think Will Triple
Five Small Biotech Stocks Analysts Think Will Triple
Forbes
Arrowhead Research
ChemoCentryx
Ziopharm
TherapeuticsMD
Dynavax
Flag link:
Dynavax initiates PhIII study it hopes will quell FDA's safety concerns
Dynavax initiates PhIII study it hopes will quell FDA's safety concerns
Fierce Vaccines
Dynavax
FDA
Heplisav
Flag link:
Dynavax: Embarking On A Run Propelled By 2 Potential Approvals
Dynavax: Embarking On A Run Propelled By 2 Potential Approvals
Seeking Alpha
Dynavax
Heplisav
Flag link:
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV
Seeking Alpha
Heplisav
Dynavax
vaccines
hepatitis B
Flag link:
Some Speculative Biotechs Making Major Moves
Some Speculative Biotechs Making Major Moves
Seeking Alpha
Dynavax
Omeros
Pacific Biosciences
Flag link: